Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET

Evangelos Konstantinou1, Konstantinou Evangelos, Theodoros Sapsakos Mariolis

  • 1National and Kapodistrian University of Athens Faculty of Nursing, Surgical Nursing Section 18 Kivelis str. 15238 Athens Greece. ekonstan30@yahoo.com

Insights

Prophylactic thyroidectomy in individuals with a RET proto-oncogene mutation prevents Medullary Thyroid Carcinoma. This study reviewed 19 young patients who underwent preventive surgery, demonstrating its effectiveness.

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Medullary Thyroid Carcinoma (MTC) is linked to RET proto-oncogene mutations.
  • Early identification and intervention are crucial for preventing MTC progression.

Purpose of the Study:

  • To evaluate the outcomes of prophylactic thyroidectomy in young individuals with a history of MTC and a detected RET proto-oncogene mutation.
  • To assess the effectiveness of preventive surgery in asymptomatic carriers.

Main Methods:

  • Retrospective review of 19 patients from 6 families heterozygote for mutant RET proto-oncogene.
  • All patients were under 20 years old and underwent total thyroidectomy.
  • Preoperative genetic testing, calcitonin level measurement, and surgical procedures including lymph node resection were performed.

Main Results:

  • All 19 patients were asymptomatic for MTC preoperatively.
  • Prophylactic thyroidectomy was performed, with lymph node resection in 73.68% of cases.
  • One patient with pheochromocytoma also underwent epinephridectomy.

Conclusions:

  • Prophylactic thyroidectomy is an effective preventive strategy for individuals with RET proto-oncogene mutations.
  • Early surgical intervention can prevent the development of Medullary Thyroid Carcinoma in at-risk populations.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...